A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
Clinical trial NCT07142707 · RECRUITING
Trial details
- NCT number
- NCT07142707
- Sponsor
- MBX Biosciences
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-03
- Primary completion
- 2026-10-30
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.